Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective Cohort Observational Study to Develop Dosing Chart Based on Patient Specific Characteristics and Ovarian Response When Follitrope™ PFS is Administered Subcutaneously to Infertility Women Patients

NCT04227171 is registered in ClinicalTrials.gov with LG Chem as lead sponsor.

NCT NCT04227171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04227171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective Cohort Observational Study to Develop Dosing Chart Based on Patient Specific Characteristics and Ovarian Response When Follitrope™ PFS is Administered Subcutaneously to Infertility Women Patients
Lead sponsor
LG Chem
Phase
Observational
Overall status
Completed
Start date
August 3, 2018
Completion date
July 31, 2020
Enrollment
534 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertile women undergoing ivf or icsi